Low-molecular-weight heparin use in special populations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15633954.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Because many obese patients and patients with underlying renal dysfunction require surgical intervention, it is important to examine the dosage recommendations and monitoring required with low-molecular-weight heparins.
Medical subject headings
- Anticoagulants
- Heparin, Low-Molecular-Weight
- Kidney Failure, Chronic
- Obesity
- Thromboembolism